naringenin has been researched along with Corneal Angiogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, Z; Lu, P; Ma, Y; Song, F; Wang, Y; Yang, J; Zhang, J; Zhang, Y; Zheng, C | 1 |
| Casella, AMB; Crespigio, J; Domiciano, TP; Hohmann, MSN; Oguido, APMT; Pinho-Ribeiro, FA; Verri, WA | 1 |
2 other study(ies) available for naringenin and Corneal Angiogenesis
| Article | Year |
|---|---|
Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization:
Topics: Animals; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Cornea; Corneal Neovascularization; Disease Models, Animal; Drug Carriers; Drug Liberation; Drug Stability; Emulsions; Flavanones; Humans; Hydrogen-Ion Concentration; Male; Matrix Metalloproteinase 14; Mice; Mice, Inbred BALB C; Ophthalmic Solutions; Particle Size; Rabbits; Surface Properties; Vascular Endothelial Growth Factor A | 2022 |
Naringenin Eye Drops Inhibit Corneal Neovascularization by Anti-Inflammatory and Antioxidant Mechanisms.
Topics: Alkalies; Animals; Antioxidants; Burns, Chemical; Corneal Neovascularization; Cytokines; Disease Models, Animal; Epithelium, Corneal; Estrogen Antagonists; Eye Burns; Flavanones; Male; Mice; Microscopy, Confocal; Ophthalmic Solutions | 2017 |